comparemela.com

Latest Breaking News On - Scancell avidimab - Page 1 : comparemela.com

Scancell : Interim Report 31st October 2023

CHIEF EXECUTIVE OFFICER S STATEMENT I am pleased to report the Group s interim results for the six-month period ended 31 October 2023. During the period, Scancell.

United-kingdom
Lindy-durrant
Scancell-moditope
Scancell-avidimab
Scancell-immunobody
Company-moditope
Scancell-holdings
Registrar-of-companies
European-union
Convertible-loan-notes
Financial-position
Derivative-liabilities

Scancell Holdings doses first patient with iSCIB1+

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF), a developer of immunotherapies for cancer and infectious diseases, has reached a pivotal milestone in its.

Ls-prasad-kellati
Lindy-durrant
Scancell-avidimab
Scancell-holdings
Royal-preston

Scancell to broaden SCOPE trial with third cohort

Scancell to broaden SCOPE trial with third cohort
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
Scancell-avidimab
Lindy-durrant
Scancell-holdings

Scancell to broaden SCOPE trial with third cohort

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) has received the go-ahead from UK medical regulator MHRA to add another group of patients to its ongoing SCOPE.

United-kingdom
Lindy-durrant
Scancell-avidimab
Scancell-holdings

Investegate |Scancell Hlds Announcements | Scancell Hlds: Preclinical data at the EuroMAbNet Annual Meeting

Investegate announcements from Scancell Hlds, Preclinical data at the EuroMAbNet Annual Meeting

Germany
Hamburg
Nick-adams-harland
Scancell-avidimab
John-chiplin
Freddy-crossley-emma-earl
Lindy-durrant
Company-glymab
Scancell-holdings
Company-avidimab
Panmure-gordon-united-kingdom-limited-nominated-adviser
Stifel-nicolaus-europe-limited-joint-broker

vimarsana © 2020. All Rights Reserved.